Prestige Consumer Healthcare
Corporate brand
UnclaimedPrestige Consumer Healthcare is an American consumer-healthcare company that markets and distributes over-the-counter medicines, personal-care products, dietary supplements, and selected household products.
Last updated August 22, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Prestige Consumer Healthcare is an American consumer-healthcare company headquartered in Tarrytown, New York. The company operates a portfolio model built around established over-the-counter healthcare and personal-care brands, many of which were acquired from larger consumer-products or pharmaceutical companies and subsequently managed as focused, category-specific businesses. Its portfolio has included products for sore throats, eye care, wart treatment, motion sickness, denture care, headaches, children's health, digestive support, oral care, hydration, and other everyday consumer-health needs. The business traces part of its corporate history to the 1996 combination of Medtech Products, Prestige Brands International, and the Spic and Span Company. Prestige Brands Holdings was subsequently established in 1999 with a strategy of acquiring recognizable but frequently non-core or underinvested brands, refreshing their marketing, extending them into adjacent products, and distributing them through mass retail, drugstores, grocery stores, club channels, e-commerce, and other consumer outlets. This approach positioned the company differently from research-driven pharmaceutical manufacturers: its emphasis was on brand management, commercialization, distribution, and lifecycle development of nonprescription products. A major phase of expansion began with the acquisition of the Blacksmith Brands portfolio in 2010. In 2011, the company agreed to purchase 17 consumer-health brands from GlaxoSmithKline, including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex, and Tagamet. The transaction materially broadened Prestige's presence in analgesics, digestive health, allergy and sleep-related products, and dietary supplements. Further international expansion followed through the 2013 acquisition of Care Pharmaceuticals in Australia and the 2014 purchase of Hydralyte in Australia and New Zealand. Hydralyte gave the company a significant oral-rehydration brand in those markets. Prestige also expanded its domestic portfolio through acquisitions of Insight Pharmaceuticals in 2014, DenTek Oral Care in 2015, and C.B. Fleet in 2016. These transactions added feminine-care, oral-care, gastrointestinal, and other over-the-counter product categories. In 2021, the company acquired consumer-health assets from Akorn Operating Company, adding TheraTears and related products to its eye-care portfolio. The company has also simplified its portfolio at various points. It sold the Denorex and Prell shampoo brands in 2009, later divested Fiber Choice, PediaCare, New-Skin, and Dermoplast, and sold its household-cleaning division in 2018. These disposals reflected a continuing effort to concentrate on consumer-healthcare categories rather than maintain a broad collection of unrelated products. Prestige's portfolio has included Chloraseptic, Clear Eyes, Compound W, Dramamine, Efferdent, Luden's, BC Powder, Goody's, PediaCare, Little Remedies, and Beano, among other brands. The company also operates a manufacturing facility in Lynchburg, Virginia. Ron Lombardi became president and chief executive officer on June 1, 2015, succeeding Matthew Mannelly. Prestige Consumer Healthcare's business model remains centered on acquiring, maintaining, marketing, and extending established consumer-health brands rather than developing prescription medicines through large-scale research programs.
History
Prestige Consumer Healthcare developed from a group of consumer-product businesses that were combined in 1996, including Medtech Products, Prestige Brands International, and the Spic and Span Company. Prestige Brands Holdings was established in 1999 and adopted a focused acquisition-and-brand-development model. Rather than concentrating on the discovery of new prescription medicines, the company sought established consumer brands that were often no longer central to the strategies of larger pharmaceutical or consumer-products corporations. Prestige's role was to acquire, market, distribute, and extend those brands through retail and healthcare channels. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner. The company then continued to enlarge its portfolio through targeted acquisitions. In 2010 it purchased five brands from Blacksmith Brands. The following year it agreed to buy 17 brands from GlaxoSmithKline, including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex, and Tagamet. That transaction expanded Prestige's exposure to analgesics, digestive health, supplements, and other mature over-the-counter categories. Prestige's international presence grew in the following years. In 2013 it acquired Care Pharmaceuticals, an Australian marketer and distributor serving children and adults. In 2014 it purchased Hydralyte in Australia and New Zealand, adding an established oral-rehydration brand. The same year, it announced the acquisition of Insight Pharmaceuticals, broadening its portfolio in feminine care and other over-the-counter segments. In 2015, the company announced the purchase of DenTek Oral Care, strengthening its oral-care presence. Ron Lombardi replaced Matthew Mannelly as president and chief executive officer on June 1 of that year. The acquisition strategy continued in 2016, when Prestige agreed to buy C.B. Fleet from Gryphon Investors. At the same time, the company periodically sold brands that no longer fit its priorities. Denorex and Prell were sold in 2009, while Fiber Choice, PediaCare, New-Skin, and Dermoplast were later divested. In 2018 Prestige sold its household-cleaning division, reinforcing a concentration on healthcare and personal-care categories. In 2021, Prestige acquired consumer-health assets from Akorn Operating Company. The transaction added TheraTears and other products, extending the company's position in eye care. Across these stages, the company has maintained a portfolio approach built around recognizable brands such as Chloraseptic, Clear Eyes, Compound W, Dramamine, Efferdent, Luden's, BC Powder, Goody's, Little Remedies, Beano, Hydralyte, DenTek, and TheraTears. Its headquarters are in Tarrytown, New York, and it operates a manufacturing facility in Lynchburg, Virginia.
- 2021
Akorn consumer-health assets are acquired
[1]Prestige acquired consumer-health assets from Akorn, including TheraTears and other products.
- 2018
Household-cleaning division is sold
[1]Prestige sold its household-cleaning supply division and concentrated more heavily on healthcare categories.
- 2016
C.B. Fleet is acquired and selected brands are divested
[1]Prestige agreed to acquire C.B. Fleet and divested Fiber Choice, PediaCare, New-Skin, and Dermoplast.
- 2015
DenTek acquisition and CEO transition
[1]Prestige announced the acquisition of DenTek Oral Care, while Ron Lombardi became chief executive officer on June 1.
- 2014
Hydralyte and Insight Pharmaceuticals transactions
[1]Prestige acquired Hydralyte in Australia and New Zealand and announced an agreement to acquire Insight Pharmaceuticals.
- 2013
Care Pharmaceuticals is acquired
[1]The acquisition expanded Prestige's Australian consumer-healthcare operations.
- 2011
GlaxoSmithKline brand portfolio is added
[1]Prestige agreed to purchase 17 consumer-health brands from GlaxoSmithKline.
- 2010
Blacksmith Brands portfolio is acquired
[1]Prestige acquired five brands from Blacksmith Brands.
- 2009
Denorex and Prell are divested
[1]Prestige sold the Denorex and Prell shampoo brands.
- 2004
Ownership changes from MidOcean Partners to GTCR Golder Rauner
[1]MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Products and positioning
A brand-management and distribution platform focused on established, everyday consumer-healthcare products. Prestige generally emphasizes recognizable brands, broad retail availability, category expertise, product extensions, and the revitalization of mature or non-core brands acquired from larger companies.
Sore-throat relief
Chloraseptic
Chloraseptic is a line of consumer products for temporary sore-throat relief. It is associated with sprays and related throat-care formats sold through over-the-counter healthcare channels.
Eye care
Clear Eyes
Clear Eyes is an over-the-counter eye-care brand offering products intended for common temporary eye symptoms. It is one of Prestige's principal brands in the consumer eye-care category.
Wart treatment
Compound W
Compound W is a consumer wart-treatment brand. Its products occupy the self-care segment of over-the-counter dermatological treatment and are distributed through ordinary retail healthcare channels.
Motion-sickness treatment
Dramamine
Dramamine is a motion-sickness treatment brand included in Prestige's consumer-health portfolio. It serves travelers and other consumers seeking nonprescription relief from motion-related nausea.
Denture care
Efferdent
Efferdent is a denture-care brand offering products used in the cleaning and maintenance of removable dental appliances.
Throat drops
Luden's
Luden's is a throat-drop brand positioned within everyday throat comfort and cough-related consumer self-care. It forms part of Prestige's longstanding oral and respiratory-care portfolio.
Analgesics
BC Powder
BC Powder is an over-the-counter analgesic brand known for powdered headache-relief products. Prestige added it through the 2011 acquisition of brands from GlaxoSmithKline.
Analgesics
Goody's
Goody's is an over-the-counter headache and pain-relief brand. Its powder-based products became part of Prestige's analgesics portfolio through the GlaxoSmithKline transaction.
Children's healthcare
PediaCare
PediaCare was a children's over-the-counter healthcare brand formerly held by Prestige. The company later divested it as part of portfolio rationalization.
Children's healthcare
Little Remedies
Little Remedies is a children's consumer-healthcare line included among Prestige's brands. It focuses on products designed for common health needs of infants and children.
Digestive health supplement
Beano
Beano is a digestive-health dietary supplement brand acquired from GlaxoSmithKline. It is marketed for consumer management of digestive discomfort associated with certain foods.
Oral rehydration
Hydralyte
Hydralyte is an oral-rehydration brand serving Australia and New Zealand. Prestige acquired it in 2014 as part of its expansion in international consumer healthcare.
Oral care
DenTek
DenTek is an oral-care brand acquired by Prestige in a transaction announced in 2015. Its portfolio added consumer products for home dental and oral hygiene.
Eye care
TheraTears
TheraTears is an eye-care brand added to Prestige's portfolio through the 2021 acquisition of consumer-health assets from Akorn Operating Company.
Brand decisions
2021
Acquisition of Akorn consumer-health assetsM&ABackground
Prestige sought to add consumer-health assets in established categories, including eye care.
Action taken
The company acquired consumer-health business assets from Akorn Operating Company.
Aftermath
The transaction added TheraTears and other products to Prestige's portfolio.
Purchase price. $228.9 million (July 2021 transaction)
2018
Exit from household cleaningStrategyBackground
Prestige reviewed its portfolio to concentrate resources on consumer-healthcare and related categories.
Action taken
The company sold its household-cleaning supply division.
Aftermath
The divestiture reduced exposure to household cleaning and sharpened the company's healthcare-oriented positioning.
2016
Agreement to acquire C.B. FleetM&ABackground
Prestige continued its strategy of building scale through established consumer-health brands.
Action taken
Prestige agreed to buy C.B. Fleet from private-equity firm Gryphon Investors.
Aftermath
The deal added C.B. Fleet's consumer-health products while Prestige also divested several brands that no longer fit its portfolio priorities.
Approximate announced purchase price. $825 million (December 2016 announcement)
2015
Acquisition agreement for DenTek Oral CareM&ABackground
Prestige aimed to deepen its presence in consumer oral care.
Action taken
The company announced an agreement to acquire privately held DenTek Oral Care.
Aftermath
DenTek expanded Prestige's portfolio with oral-care products distributed to consumers through retail channels.
Announced purchase price. $225 million (November 2015 announcement)
2014
Acquisition agreement for Insight PharmaceuticalsM&ABackground
Prestige pursued expansion in feminine care and other over-the-counter healthcare categories.
Action taken
Prestige announced a definitive agreement to acquire Insight Pharmaceuticals for cash.
Aftermath
The proposed transaction added Insight's feminine-care and other consumer-health products to Prestige's acquisition pipeline.
Announced purchase price. $750 million (April 2014 announcement)
2011
Purchase of GlaxoSmithKline consumer-health brandsM&ABackground
Prestige sought to expand its portfolio of established over-the-counter and consumer-health products through a large brand acquisition.
Action taken
The company agreed to purchase 17 brands from GlaxoSmithKline, including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex, and Tagamet.
Aftermath
The transaction broadened Prestige's presence across analgesics, digestive health, supplements, sleep-related products, and other consumer-health categories.
Announced purchase price. $660 million (December 2011 announcement)
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/prestige-consumer-healthcare · Editorial policy · How profiles are compiled